According to SCMP: According to the recently announced third quarter performance forecasts, all major listed breeding companies have recorded varying degrees of profit growth. Meanwhile, Huaan Securities believes the price of live pigs has stabilized and rebounded, and is expected to remain relatively high in 2020-2021. In terms of new IPOs, Sichuan Tianzow Breeding Technology Co., Ltd. (1248.HK), a newcomer in the industry, began its public offering period from October 29 to November 6 and has priced its shares at a price ranging between HK$26.00 to HK$38.80. The company plans to become listed publicly on the Hong Kong Main Board…
Author: Marie Jones
Raffles Financial Group Limited (CSE: RICH) (FSE: 4VO) (OTC: RAFFF) (“Raffles” or “the Company”) today announces its financial results for the fiscal year ended June 30, 2020, highlighted by revenue of $8,866,672 and adjusted comprehensive income before other items and income tax expenses of $12,220,573. All amounts expressed are in Singapore dollars. 2020 Financial Highlights: – Total Revenue of $8,866,672 (2019: $11,533,334) – Adjusted comprehensive income before other items and income tax expenses3 of $12,220,573 (2019: $10,750,652) – Cash Flow from operations of $7,044,654 (2019: $11,002,734) – The Company generated cash inflow from financing activities of $20,296,000 (2019: cash outflow…
Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies. Importantly, the AU/EU model allows biotechs to keep their data and trial management in Australia, and take advantage of the Australian cash rebate of up to 43.5% on clinical trial costs, throughout all study phases, across both regions.…
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has partnered with Endpoints News to produce an exceptional step-by-step webinar on how to run your trial in Australia, and why Agilex Biolabs is the leading biolabs partner. Watch here (no charge) https://tinyurl.com/yyzf6o44 Agilex Biolabs is known internationally for its continued investment in the latest technology, and for attracting some of the leading scientists from Australia and around the world. The webinar was launched as part of Agilex Biolabs’ presence at Bio Europe. Click here to meet Agilex Biolabs at Bio Europe via the partneringone tool. https://informaconnect.com/bio-europe-virtual/ Dr…
TOKYO, Oct 27, 2020 – Showa Denko (SDK; TSE:4004) decided at its Board of Directors’ meeting today to split its business in optical semiconductors and rare earth alloys through an absorption-type company split effective January 1, 2021 (hereinafter “the Company Split”). Showa Denko Photonics Co., Ltd., a wholly-owned subsidiary of SDK, will succeed to the business. As the Company Split is to be implemented through a simplified absorption-type company split between SDK and its wholly-owned subsidiary, part of details is omitted in this disclosure. 1. Objective of the Company Split In its medium-term business plan “The TOP 2021,” SDK aims…
Wintermar Offshore Marine (WINS:JK) has announced results for 9M2020. Wintermar’s Owned Vessel revenue for 9M2020 was 17% lower YOY at US$24.6 million and there was a slight improvement on a quarterly basis in 3Q2020 compared to 2Q2020. –Owned Vessel Division For the 9M2020 period, Owned Vessel Division recorded a gross loss of US$2.8 million, largely due to cancellations and postponement of contracts caused by the pandemic. Cost efficiency measures and a streamlining of the fleet undertaken since last year led to a 14% YOY decline in Owned Vessel direct expenses, which helped mitigate some of the losses. On a quarterly…
Pacific Green Technologies, Inc. (the “Company” or “PGTK”, (OTCQB:PGTK)) announces the appointment of Xavier Lara as Senior Vice President, Concentrated Solar Power, effective October 26, 2020. Xavier is one of the pre-eminent experts in the Concentrated Solar Power (CSP) sector, with over twenty-five years’ experience, including various senior-level roles for AELIUS Engineers and Consultants, Empresarios Agrupados, ACWA Power and NextEra Energy. Xavier joins Pacific Green having recently served as Project Director on billion dollar Cleantech developments around the world. Scott Poulter, PGTK’s Chief Executive commented: “As we continue to build on our existing CSP capabilities, we believe Xavier’s unparalleled sales…
Infinito Wallet, the leading multi-crypto wallet today announces a multitude of valuable new features targeted at ADA users. These include support for new Cardano blockchain upgrade, staking and trading features for ADA assets, as well as full wallet compatibility with Daedalus and Yoroi Wallet by allowing users to import 24-word and 15-word passphrase, respectively into Infinito Wallet. This new app release further cements Infinito Wallet’s long-standing position to make crypto easy for mass adoption, still with extensive support for the Cardano community. Starting from September 2018, through a strong collaboration with IOHK, Infinito Wallet has been one of the first…
Raffles Financial Group Limited (CSE: RICH) (FSE: 4VO) (OTC: RAFFF) today announced that its wholly owned subsidiary Raffles Financial Private Limited (“Raffles”) has entered into a 3-Year Strategic Cooperation Agreement (the “Agreement”) with Shanghai Lingang Technology Entrepreneurship Center Co., Ltd. (“Lingang”) on October 22, 2020 (the “Cooperation”). Raffles, equipped with professional background and experience in corporate finance, will support Lingang in building an incubation centre for fast-growing tech firms with leading disruptive technologies. Raffles’ role is to assist in screening, inviting, coaching, developing “mega unicorn potential” companies with the aim to secure funding via public listing on major stock exchanges…
Genadi Man, CEO of kasko2go, has announced that his company’s advanced open source solution would be made available free of charge, to reduce the dramatic losses in the car insurance industry with a high-tech open source product. Speaking at this year’s telematics trade fair (Leipzig, Germany, 6-7 October), kasko2go said it aims to make the business model of Swiss and foreign insurers “significantly more profitable” kasko2go has been developed and tested on more than 100,000 drivers in Europe. In Switzerland the software has been on the market for almost two years. The decision is to give the 900 European and…